< Back to Search

Neurology® Podcast - May 22 2018 Issue

ABBY: A Phase 2 randomized trial of crenezumab in mild-to-moderate Alzheimer Disease

1. Featured Article: ABBY: A Phase 2 randomized trial of crenezumab in mild-to-moderate Alzheimer's Disease 2. What’s Trending: Epilepsy Birth Control Registry This Neurology® Podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the May 22, 2018, print issue of Neurology. In the first segment, Dr. Jeff Burns talks with Dr. Jeffrey Cummings about results from the ABBY clinical trial on crenezumab as a potential treatment for mild to moderate Alzheimer Disease. For the “What’s Trending” segment, Dr. Katherine Zarroli interviews Dr. Andrew Herzog about the Epilepsy Birth Read More

Download this Episode

Episode Segments

Top

FOR MORE INFORMATION

Email pbaskin@neurology.org

Footer